Research Proposal Template in Latex

INSTITUTIONAL LEGAL ARCHITECTURE: RESEARCH PROPOSAL & SPONSORED RESEARCH AGREEMENT

DOCUMENT ID: SRA-LEG-2026-V1.0
EFFECTIVE DATE: [Effective Date]
VERSION: 1.0 (Institutional Master)
GOVERNING JURISDICTION: State of [State] / Federal Laws of the United States

---

SECTION 1: STATUTORY & LEGAL COMPLIANCE NOTICE

CRITICAL LEGAL NOTICE: This Sponsored Research Agreement and accompanying Research Proposal framework is drafted to meet institutional, corporate, and academic compliance standards. The enforceability of these provisions depends on exact execution, complete data input, and adaptation to local, state, and federal statutory mandates (including the Uniform Commercial Code, federal grant regulations, and state contract law). Parties must consult qualified legal counsel prior to execution. This document creates binding legal obligations regarding intellectual property, financial liability, and proprietary data.

---

SECTION 2: PARTIES & RECITALS

This Sponsored Research Agreement (the "Agreement"), entered into as of [Effective Date] (the "Effective Date"), is made by and between:

1. [Institution/Company Full Legal Name], a [State of Incorporation] [corporation/non-profit/university], having its principal place of business at [Principal Address] (hereinafter referred to as the "Research Institution" or "Party A"), and
2. [Client/Sponsor Full Legal Name], a [State of Incorporation] [corporation/entity type], having its principal place of business at [Principal Address] (hereinafter referred to as the "Sponsor" or "Party B").

RECITALS:

• WHEREAS, Sponsor desires to engage Research Institution to perform certain scientific, technical, and academic research as outlined in the Research Proposal attached hereto as Exhibit A;
• WHEREAS, Research Institution possesses the requisite expertise, personnel, and facilities to conduct said research under academic and professional standards;
• WHEREAS, the parties intend to collaborate under the terms and conditions set forth herein to govern the performance, funding, and intellectual property resulting from such research.

NOW, THEREFORE, in consideration of the mutual covenants contained herein and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows:

---

SECTION 3: EXHAUSTIVE OPERATIVE CLAUSES & LEGAL TERMS

1. Scope of Services & Research Engagement

1.1 Research Program. Research Institution shall use commercially reasonable efforts to conduct and complete the research project entitled "[Title of Research Project]" (the "Research Program") as specifically detailed in the Research Proposal attached hereto as Exhibit A. 1.2 Standard of Performance. Research Institution shall perform the Research Program in accordance with professional research standards and applicable federal, state, and local laws. The Research Program shall be supervised by [Principal Investigator Name] (the "Principal Investigator"). If the Principal Investigator becomes unable or unwilling to continue the Research Program, Research Institution shall promptly notify Sponsor and propose a mutually acceptable replacement. If a replacement is not agreed upon within thirty (30) days, either party may terminate this Agreement pursuant to Section 3. 1.3 Deliverables. Research Institution shall provide Sponsor with written progress reports and final research reports in accordance with the schedule and milestones set forth in Exhibit A.

2. Compensation & Payment Terms

2.1 Total Consideration. In consideration for the performance of the Research Program and the grant of rights herein, Sponsor shall pay to Research Institution the total sum of [Amount in USD] (USD [Written Amount]) in accordance with the milestone payment schedule set forth in Exhibit B. 2.2 Invoicing. Research Institution shall issue invoices to Sponsor for each milestone or installment upon completion of the corresponding project phase as outlined in Exhibit B. Sponsor shall pay all undisputed invoices within [Number, e.g., 30] days of receipt. 2.3 Late Interest. Any undisputed amount not paid when due shall accrue interest at the lesser of one and one-half percent (1.5%) per month or the maximum rate permitted by applicable law, calculated from the date due until paid in full. 2.4 Taxes. All payments stated herein are exclusive of all federal, state, municipal, or other government excise, sales, use, occupational, or like taxes now in force or enacted in the future. Sponsor shall be responsible for all such taxes, excluding taxes based upon Research Institution's net income.

3. Term & Termination

3.1 Term. This Agreement shall commence on the Effective Date and shall continue until [Completion Date or "the completion of the Research Program"], unless earlier terminated in accordance with this Section 3 (the "Term"). 3.2 Termination for Convenience. Sponsor may terminate this Agreement at any time, with or without cause, upon providing [Number, e.g., 60] days' prior written notice to Research Institution. Upon such termination, Sponsor shall pay Research Institution for all non-cancelable obligations, committed costs, and pro-rata operational expenses incurred up to the effective date of termination. 3.3 Termination for Cause. If either party materially breaches any provision of this Agreement, the non-breaching party may provide written notice specifying the breach. If the breaching party fails to cure such material breach within [Number, e.g., 30] days of receipt of such notice, the non-breaching party may terminate this Agreement immediately by written notice. 3.4 Survival. Termination or expiration of this Agreement shall not affect any rights or obligations that have accrued prior to termination, and provisions relating to Confidentiality, Intellectual Property, Limitation of Liability, and Governing Law shall survive indefinitely.

4. Intellectual Property Ownership & Work Made for Hire

4.1 Background IP. Each party shall retain sole and exclusive ownership of all right, title, and interest in and to any intellectual property, technology, know-how, and trade secrets owned or controlled by such party prior to the Effective Date or developed independently of this Agreement ("Background IP"). 4.2 Project IP. "Project IP" shall mean all inventions, discoveries, data, software, copyrightable works, and technology conceived, first reduced to practice, or generated solely by Research Institution personnel in the direct performance of the Research Program. 4.3 Ownership of Project IP. Project IP generated solely by Research Institution shall be owned by [Research Institution / Sponsor / Jointly Owned]. If owned by Research Institution, Research Institution hereby grants Sponsor a [exclusive/non-exclusive], [worldwide/domestic], [royalty-bearing/royalty-free] option to negotiate an exclusive commercial license to such Project IP under commercially reasonable terms to be negotiated in good faith. 4.4 Joint IP. Intellectual property jointly created by employees of both parties shall be jointly owned by the parties, with each party having the unrestricted right to practice and exploit the Joint IP without accounting to the other party, subject to separate written agreements.

5. Mutual Confidentiality & Non-Disclosure

5.1 Definition. "Confidential Information" means any proprietary or confidential data, technical information, trade secrets, know-how, financial data, or research plans disclosed by one party ("Disclosing Party") to the other party ("Receiving Party") that is marked as confidential or, if disclosed orally, summarized in writing within thirty (30) days of disclosure as confidential. 5.2 Obligations. Receiving Party shall protect the Disclosing Party's Confidential Information with the same degree of care it uses for its own confidential information (but not less than reasonable care), shall not disclose it to any third party except to employees and contractors bound by similar confidentiality obligations, and shall use it solely for the performance of this Agreement. 5.3 Exclusions. Confidential Information shall not include information that: (a) is or becomes publicly known through no breach by Receiving Party; (b) was already in Receiving Party's possession without obligation of confidentiality; (c) is independently developed by Receiving Party without reference to Disclosing Party's Confidential Information; or (d) is required to be disclosed by law or court order, provided prompt written notice is given to Disclosing Party.

6. Representations & Warranties

6.1 Mutual Warranties. Each party represents and warrants that: (a) it has the full corporate power and authority to enter into this Agreement; (b) the execution and delivery of this Agreement have been duly authorized; and (c) this Agreement constitutes a legal, valid, and binding obligation enforceable against it in accordance with its terms. 6.2 Research Disclaimer. RESEARCH INSTITUTION PROVIDES THE RESEARCH SERVICES AND ANY DELIVERABLES "AS IS." RESEARCH INSTITUTION MAKES NO WARRANTIES, EXPRESS OR IMPLIED, INCLUDING WITHOUT LIMITATION ANY IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, OR NONINFRINGEMENT WITH RESPECT TO THE RESEARCH PROGRAM, PROJECT IP, OR ANY RESULTS THEREOF.

7. Limitation of Liability & Indemnification

7.1 Limitation of Liability. EXCEPT FOR LIABILITY ARISING FROM BREACHES OF CONFIDENTIALITY (SECTION 5) OR INTELLECTUAL PROPERTY INFRINGEMENT, NEITHER PARTY SHALL BE LIABLE TO THE OTHER FOR ANY INDIRECT, INCIDENTAL, CONSEQUENTIAL, SPECIAL, OR PUNITIVE DAMAGES, INCLUDING LOSS OF PROFITS OR REVENUE, ARISING OUT OF OR IN CONNECTION WITH THIS AGREEMENT, EVEN IF ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. 7.2 Cap on Liability. Research Institution’s total aggregate liability under this Agreement shall not exceed the total fees actually paid by Sponsor to Research Institution under this Agreement during the twelve (12) month period preceding the event giving rise to liability. 7.3 Indemnification. Sponsor agrees to defend, indemnify, and hold harmless Research Institution, its trustees, officers, employees, and agents from and against any third-party claims, liabilities, losses, damages, or expenses (including reasonable attorneys' fees) arising out of or resulting from: (a) Sponsor’s commercialization or use of Project IP or deliverables; or (b) Sponsor’s gross negligence or willful misconduct.

8. Dispute Resolution & Arbitration

8.1 Negotiation. In the event of any dispute, controversy, or claim arising out of or relating to this Agreement, the parties shall first attempt in good faith to resolve the matter through senior management negotiations within thirty (30) days of written notice. 8.2 Binding Arbitration. If the dispute is not resolved through negotiation, it shall be settled by binding arbitration administered by the [American Arbitration Association (AAA) / JAMS] in accordance with its commercial arbitration rules. The place of arbitration shall be [City, State], and the proceedings shall be conducted in the English language before a single neutral arbitrator. The award rendered by the arbitrator shall be final and binding, and judgment may be entered upon it in any court of competent jurisdiction.

9. Governing Law & Jurisdiction

9.1 This Agreement shall be governed by, construed, and enforced in accordance with the laws of the State of [State], without regard to its conflict of laws principles. Subject to Section 8, each party irrevocably submits to the exclusive jurisdiction of the state and federal courts located in [County, State] for any action or proceeding arising out of this Agreement.

10. Miscellaneous

10.1 Severability. If any provision of this Agreement is held to be invalid, illegal, or unenforceable, the remaining provisions shall remain in full force and effect, and the invalid provision shall be modified to the minimum extent necessary to make it valid and enforceable. 10.2 Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. Execution may be accomplished via electronic signature (e.g., DocuSign or Adobe Sign), which shall have the same legal force and effect as a handwritten signature. 10.3 Entire Agreement. This Agreement, including Exhibits A and B, constitutes the entire agreement between the parties with respect to the subject matter hereof and supersedes all prior or contemporaneous oral or written agreements, negotiations, and representations. This Agreement may only be amended by a written document signed by duly authorized representatives of both parties.

---

SECTION 4: EXECUTION & FORMAL SIGNATURE BLOCKS

IN WITNESS WHEREOF, the parties hereto have caused this Sponsored Research Agreement to be duly executed by their respective authorized officers as of the Effective Date.

FOR [PARTY A / RESEARCH INSTITUTION NAME]:
Signature: _____________________________________
Printed Name: [Authorized Signatory Name]
Title: [Title / Role, e.g., Vice President of Research]
Company: [Research Institution Legal Name]
Date: [Date]

FOR [PARTY B / SPONSOR NAME]:
Signature: _____________________________________
Printed Name: [Authorized Signatory Name]
Title: [Title / Role, e.g., Chief Executive Officer]
Company: [Sponsor Legal Name]
Date: [Date]

---

SECTION 5: STEP-BY-STEP EXECUTION & FILING GUIDE

1. Review and Data Population: Open this document in Microsoft Word, Google Docs, or a LaTeX editor. Locate all bracketed placeholders (e.g., [Company Full Legal Name], [Amount in USD]) and replace them with accurate, verified factual data. Do not leave any brackets unpopulated.
2. Exhibit Verification: Ensure that Exhibit A (Detailed Research Proposal, milestones, and technical specifications) and Exhibit B (Financial Payment Schedule) are fully drafted and appended to this document prior to signing.
3. Signatory Authority Verification: Confirm that the individuals signing on behalf of both entities possess corporate or institutional authority (pursuant to corporate bylaws, board resolutions, or institutional delegations of authority) to bind their respective organizations to financial and legal obligations.
4. Digital or Wet-Ink Execution: Route the finalized PDF through a secure digital signature platform (such as DocuSign or Adobe Sign) utilizing cryptographic audit trails, or execute via traditional wet-ink signatures across identical counterparts.
5. Post-Execution Filing & Record Retention: Upon complete execution, store the master digital document in the organization’s secure Contract Management System (CMS) or physical archive. Maintain records for the duration of the Term plus the applicable state statute of limitations (typically a minimum of seven (7) years post-termination).